Stämm Biotech specializes in life sciences. Stämm designs a bioproduction system that leverages microfluidics, electroporation and robotics.
Stämm's main product is a desktop-sized bioreactor called the Bioprocessor.
The company is supported by investors and advisors including IndieBio, GridX, Draper Cygnus, and Singularity University. Tim Draper is a board member of the company.
Timeline
Funding rounds
People
Adrián Mastronardi
Advisor
Agostina Lipka
Accounting Consultant
Alejandro Kruchowski
Industrial Engineering Dept. Leader
Arturo Bianchetti, PhD.
Conicet Optics Consultant - Under S.T.A.N. contract between Conicet and Stämm
Emiliano Höss, PhD.
I.T. Dept. Leader
Federico D'Alvia Vegh
Co-founder & COO
Florencia Fernández Fox
Administrative Assistant
Gabriela Sobral
Quality Consultant
Gastón Corti
3D Printing Dept. Leader
Ignacio Campanelli
Product Leader
Isaac Aaron Rodriguez Osuna
Hardware Development Contractor
Jean-Charles Neel
Research and Development
Juan Francisco Llamazares Vegh
Co-founder & CEO
Juan Martín Cabaleiro, PhD
Conicet Microfluidics Consultant - Under S.T.A.N. contract between Conicet and Stämm
Leda Avila
Analytics Dept. Leader
Lucía Santín
Stem Cell Department Leader
Manuel Del Cogliano, PhD.
Biology Dept. Leader
Martín López Palermo
Embedded Systems Specialist
Martín Palazzo
Machine Learning & Biologic Systems Dept. Leader
Martina Casas
Communications Strategist
Micaela Ciraolo
Bioinformatics Dept. Leader
Michael Siani-Rose
Business Development
Nahuel Olaiz, PhD.
Electroporation Consultant
Nicolás Cámera
Logistics Contractor
Pablo Rodriguez
Recombinant Protein & Transfection Specialist
Further reading
Stämm: Reinventing the Bioreactor - Indie Bio - Medium
Jun Axup
Web
November 2, 2018
Documentaries, videos and podcasts
Simulation | IndieBio #237 Yuyo & Federico Vegh - Reinventing Bioreactors
December 7, 2018
Company
Biotechnology
San Francisco
Buenos Aires
Yuyo Llamazares Vegh
IndieBio
Tim Draper
SOSV
Gridx Exponential
